STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Available from:

Sanofi-Aventis Australia Pty Ltd

INN (International Name):

prochlorperazine mesilate

Pharmaceutical form:

Injection

Composition:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Administration route:

Intramuscular

Units in package:

10 x 1 mL

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Product summary:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2007-07-16